Role of Epstein-Barr Virus in Burkitt’s Lymphoma

Author(s):  
K. Takada
1999 ◽  
Vol 73 (12) ◽  
pp. 9827-9831 ◽  
Author(s):  
Jun Komano ◽  
Seiji Maruo ◽  
Koichi Kurozumi ◽  
Takanori Oda ◽  
Kenzo Takada

ABSTRACT Our previous reports indicated that Epstein-Barr virus (EBV) contributes to the malignant phenotype and resistance to apoptosis in Burkitt’s lymphoma (BL) cell line Akata (N. Shimizu, A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada, J. Virol. 68:6069–6073, 1994; J. Komano, M. Sugiura, and K. Takada, J. Virol. 72:9150–9156, 1998). Here we report that the EBV-encoded small RNAs (EBERs) are responsible for these phenotypes. Transfection of the EBER genes into EBV-negative Akata clones restored the capacity for growth in soft agar, tumorigenicity in SCID mice, resistance to apoptotic inducers, and upregulated expression of bcl-2 oncoprotein that were originally retained in parental EBV-positive Akata cells and lost in EBV-negative subclones. This is the first report which provides evidence that virus-encoded RNAs (EBERs) have oncogenic functions in BL cells.


2001 ◽  
Vol 75 (20) ◽  
pp. 9977-9982 ◽  
Author(s):  
Seiji Maruo ◽  
Asuka Nanbo ◽  
Kenzo Takada

ABSTRACT Transfection of an Epstein-Barr virus (EBV)-encoded plasmid containing EBER caused a substantial decrease in the level of plasmid containing EBV in Akata and Mutu Burkitt's lymphoma (BL) lines, but failed to do so in other BL lines. The results suggest that EBER could replace the role of EBV, but other EBV products also play a role in the growth of BL.


1988 ◽  
Vol 1 (3) ◽  
pp. 300-312 ◽  
Author(s):  
M Okano ◽  
G M Thiele ◽  
J R Davis ◽  
H L Grierson ◽  
D T Purtilo

Since the discovery of Epstein-Barr virus (EBV) from a cultured Burkitt's lymphoma cell line in 1964, the virus has been associated with Burkitt's lymphoma, nasopharyngeal carcinoma, and infectious mononucleosis. During the recent decade, EBV has been etiologically implicated in a broad spectrum of human diseases. The precise role of this virus in these diseases is not well understood, but clearly, defective immunosurveillance against the virus may permit an uncontrolled proliferation of EBV-infected cells. As a result, a growing number of cases of EBV-associated B-cell proliferative diseases or lymphoma have been noted in patients with primary and acquired immunodeficiencies. These lymphoproliferative diseases and others, such as chronic mononucleosis syndrome, are leading to new areas of investigation which are providing information regarding the pathogenetic mechanisms of EBV-induced diseases. The early accurate diagnosis of EBV infection can be achieved by performing EBV-specific serology, detecting for EBV-determined nuclear antigen in tissues, establishing spontaneous lymphoid cell lines, and using molecular hybridization techniques for demonstrating the presence of viral genome in affected lesions.


1990 ◽  
Vol 36 (3) ◽  
pp. 114-120 ◽  
Author(s):  
J. A. Goldstein ◽  
R. L. Bernstein

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0186614 ◽  
Author(s):  
Marc Jordi ◽  
Jeannine Marty ◽  
Vanessa Mordasini ◽  
Anna Lünemann ◽  
Scott McComb ◽  
...  

Cell ◽  
1981 ◽  
Vol 24 (2) ◽  
pp. 543-553 ◽  
Author(s):  
Duncan K. Fischer ◽  
George Miller ◽  
Lyn Gradoville ◽  
Lee Heston ◽  
Marien W. Weststrate ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document